Summerish lunch get-together with old and new @westermarcklab.bsky.social lab members celebrating the recent and yet-to-be announced successes. Thanks everybody.

We have a PhD student position open focusing on yet mysterious isoform of CIP2A NOCIVA that is clinically very relevant in AML, but whether this is true in breast cancer, and how, this is the question? ats.talentadore.com/apply/vaitos...

Doctoral researcher position at Westermarck laboratory, Turku Finland

A doctoral researcher position (PhD student) is available in the laboratory of Professor Jukka Westermarck at the Turku Bioscience Centre, University of Turku, Turku, Finland (https://bioscience.fi/re...

ats.talentadore.com

Today was a day for celebrations and farewells. Toasting for Jane and Aatos Erkko foundation grant and saying farewells to long term postdoc Oxana. New beginnings for both the group and her. Check out the fancy poster pillow as a farewell present by Tiina!

Skiteam #CIP2A demonstrated admirable attitude and performance on yesterday´s training session. Some of the bravest with training background from the past years already approached the 3 km track with up and downhills. #lifeinfinland @westermarcklab.bsky.social #lifeoutsidethelab

Registration is now OPEN for the cancer research community to join us for the #EACR2026 Congress! 🥳 Don't miss the opportunity to take advantage of our discounted early registration rate to attend, available until 21 April. 2026.eacr.org

Santa Claus paid a surprise visit to our last lab development meeting and brought nice @westermarcklab.bsky.social mugs as a gift to everyone, also to the naughty boy. With these images we wish everyone happy holidays and merry Christmas.

We have a group leader position open surrounded by fantastic core facilities and great science @turkubioscience.bsky.social.

Turku Bioscience@turkubioscience.bsky.social · 8mo ago

Åbo Akademi University invites applications for a fixed term position as Head of Research in Bioscience with the task to establish a new research group at our centre. The employment can commence from 1 May, 2026 for a period of 5 years. Read more and apply here: abo.rekrytointi.com/paikat/?o=A_...

Farewell to @muksha.bsky.social. a proud recipient of the first @westermarcklab mug. Huge thanks for all your contributions and best of luck on your new adventures @mdanderson.bsky.social

Great fun yesterday celebrating the recent Tillandz prize with the lab and collaborators. Also remotely joining the man of the hour, Majid Momeny aka the first author of the paper.

@srikarnagelli.bsky.social back on the crime scene. Always good to have alumni visiting the lab and sharing their new knowledge

Congrats @shrutibhardiya.bsky.social @westermarcklab.bsky.social for winning the best poster prize at 7th @fibtra.bsky.social annual Brain Tumor meeting. Excellent meeting, thanks to all organisers 💪

Very exciting talk by Alberto Ballestin on acute impact of surgery on glioblastoma tissue @fibtra.bsky.social annual symposium in Turku.

#CIP2A has a druggable pocket. I am thrilled to announce that the last of my #CIP2A bucket list items, established 2007 has finally been accomplished. The work now out in BioRxiv reports a small molecule druggable pocket on CIP2A 1/2 www.biorxiv.org/content/10.1...

Modulation of CIP2A dimerization and protein stability via druggable pocket

Cancerous inhibitor of PP2A (CIP2A) supports malignant growth across several cancer types. CIP2A is also a synthetic lethal therapy target for BRCA-mutant cancers. In addition, CIP2A causes Alzheimer'...

biorxiv.org

Have you heard of #CIP2A, a hot new kid on the block of genome integrity and DNA repair? Funny enough, most of these papers hardly mention CIP2A as PP2A inhibitor covered by about 400 papers. This is really exciting developments for sure, an eventually these oncogenic arms of CIP2A will merge.

#careergoals after all these years I was finally rewarded by a whiteboard in my office.😁 Had to start using it immediately.

Elias Tillandz Prize awarded at the BioCity Symposium to scientific publications on breast cancer recurrence and cancer gene overactivation www.utu.fi/en/news/pres...

Elias Tillandz Prize awarded at the BioCity Symposium to scientific publications on breast cancer recurrence and cancer gene overactivation

The Elias Tillandz prize for the best scientific publication of 2024 was presented for two groundbreaking cancer studies.

utu.fi

August issue now online! ➡️ www.embopress.org/toc/17574684... The cover highlights the study by X Qiao, J Routila, J Westermarck, S Ventelä & al @westermarcklab.bsky.social showing that LIMA1 detection can be used for #HNSCC patients stratification Scientific image by M. Peltola, Thestra Oy, Turku

EMBO Molecular Medicine: Vol 17, No 8

EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

embopress.org

We are on the cover! Or what is in the cover is way more important than we, it's evidence that simple IHC assay could be used for recognising #HNSCC patients based on their outcome after surgery-only therapy. The actual cover and the article can be found here: www.embopress.org/doi/full/10....

Particularly proud of this collaboration with Sami Ventela and all Finnish #HNSCC clinics revealing LIMA1-alpha as translatable biomarker for selection of HNSCC patients for surgery-only therapies. www.utu.fi/en/news/pres... www.embopress.org/doi/full/10....

New diagnostic breakthrough predicts which head and neck cancer patients can be cured with surgery alone

Researchers developed a diagnostic test based on the LIMA1-alpha protein to distinguish patients with head and neck squamous cell carcinoma who can be cured with surgery alone, without the need for

utu.fi

Very nice bioinformatics analysis of the role of #CIP2A in ovarian cancer by @karteris.bsky.social rdcu.be/exid3

Emerging roles of the cancerous inhibitor of protein phosphatase 2A (CIP2A) in ovarian cancer

Scientific Reports - Emerging roles of the cancerous inhibitor of protein phosphatase 2A (CIP2A) in ovarian cancer

rdcu.be

Lab cleaning day is one of the important @westermarcklab.bsky.social traditions. This year the after-cleaning pizzas were enjoyed in sunny Kupittaa park. Thanks Tiina for organization and everyone for your efforts

Are you looking to start your #lab in a fantastic scientific 🧪environment, with great colleagues, and in a spectacular place to live? Then check out our open #junior #faculty position at the Department of Oncology, University of Lausanne, Switzerland: www.unil.ch/dof/en/home/... ⏰ Deadline 27 June

We’ve just marked a major milestone - our community of cancer researchers now numbers 14 000 members, working across 117 countries worldwide 🎉 Thank you to you, our members, for your ongoing support and commitment to advancing cancer research. Your passion and dedication inspire everything we do.

Fantastic EACR @helloeacr.bsky.social annual congress in Lisbon. Great talks Great atmosphere Great to meet all old and new friends

Lukijoilta | Tohtorintutkinto tulisi ottaa OKM:n ylimmän johdon pätevyysvaatimukseksi www.ts.fi/lukijoilta/6...

Lukijoilta | Tohtorintutkinto tulisi ottaa OKM:n ylimmän johdon pätevyysvaatimukseksi

OKM:n kansliapäällikön pätevyysvaatimusten korottaminen siten, että tiedepolitiikkaamme johdettaisiin vähintäänkin tohtoritutkinnon antaman tutkimuskokemuksen tuella, olisi mielipidekirjoittajien muka...

ts.fi

Absolutely catapulting quadrable WEKK (Westermarck, Elenius, Kurppa, Kauko) retreat @Villa Wolax. Fantastic science, discussions, sauna, food, wine, colleagues @turkubioscience.bsky.social @medicity.bsky.social

Want to relocate to Finland as a professor in the fields of basic, clinical, or translational medicine. An exciting funding opportunity. Please be on contact if I can be of any help. www.sigridjuselius.fi/en/apurahat/...

Professorship (5 years) - Sigrid Jusélius Foundation

With the overall aim of supporting Finnish medical research to combat diseases that are devastating to humankind, the Sigrid Jusélius […]

sigridjuselius.fi

Early-stage, curiosity-driven cancer research is the cornerstone of future medical breakthroughs. Let's #KeepResearchCurious ✨